Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013

Costa, Ricardo Filipe Alves; Longatto‐Filho, Adhemar; Vazquez, Fabiana de Lima; Pinheiro, Céline; Zeferino, Luíz Carlos; Fregnani, José Humberto Tavares Guerreiro

doi:10.1186/s12885-018-4047-9

Cited by 25 publications

(26 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…That is, we expect a similar (unmeasured) HPV prevalence in the Pap arm and therefore at least 5% to 6% of women ($6-7 women) in the Pap arm should have had ASC-USþ cytology (44)(45)(46)(47). This may be the result of underperforming Pap testing, as has been observed in many places in Brazil (48).…”

Section: Discussionmentioning

confidence: 82%

Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil

Castle

Silva

Consolaro

et al. 2019

Cancer Prevention Research

View full text Add to dashboard Cite

Most cervical cancers occur in women who do not participate in cervical-cancer screening. We therefore evaluated adherence to screening for clinic-based Pap testing, self-collected sampling for HPV testing, and choice of the 2 among 483 unscreened/underscreened women in Brazil. Three public Basic Health Units (BHU) were each randomly assigned to three arms: (i) Pap testing at the BHU (N ¼ 160), (ii) "Self&HPV" (self-collection for HPV testing) (N ¼ 161), and (iii) "Choice" between self-collection and HPV testing and Pap test at the local BHU (N ¼ 162). The theory-based (PEN-3 and Health Belief Model) intervention in all three arms was implemented by trained Community Health Workers (CHW) at participants' home. With the first invitation, 60.0% in the Pap arm, 95.1% [154 of 161 (95.7%) who selected Self&HPV and 0 of 1 (0.0%) a Two-sided, Fisher exact test; bolded values highlight statistical significance (P < 0.05). b Among women ages 50 and older. c Women had undergone screening in <4 years were ineligible for the study.Castle et al.

show abstract

Section: Discussionmentioning

confidence: 82%

Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil

Castle

Silva

Consolaro

et al. 2019

Cancer Prevention Research

View full text Add to dashboard Cite

show abstract

“…Because of the high prevalence of high‐risk HPV among women living with HIV, as well as its association with cervical lesions and cancer, it is necessary to improve cervical cancer screening through HPV‐DNA detection and genotyping testing 4,5 . This strategy will enable monitoring and evaluation of the efficacy of HPV vaccines and may help in widening cervical cancer screening in areas where cytology test (Papanicolaou smear) coverage is less effective, such as in North and Northeast Brazil 6,7 …”

Section: Introductionmentioning

confidence: 99%

Prevalence and genotype distribution of human papillomavirus in women living with HIV/AIDS in an area of Northeast Brazil

Silva

Santos

et al. 2020

Journal of Medical Virology

View full text Add to dashboard Cite

Women infected by human immunodeficiency virus (HIV) are more likely to manifest oncogenic viral infections including human papillomavirus (HPV). It was investigated the HPV prevalence, genotype distribution and HPV relationship with cervical lesions among women living with HIV in Sergipe state, Northeast Brazil. A prevalence survey was conducted including 270 HIV‐infected women who attended the reference center for HIV in Sergipe from August 2014 to November 2017. Cervical samples were processed by the polymerase chain reaction for HPV‐DNA detection. Among the 270 HIV‐infected women, 190 (70.4%) were between 26 and 49 years old and 159 (55.6%) were coinfected with HPV. Among the coinfected women, 24 viral types were identified; 113 (72%) subjects had high‐risk HPV types, and the most prevalent was HPV 16 (53/35.3%). Positive HPV status was statistically associated with having 0 to 8 years of schooling compared with ≥9 years of schooling; and have been diagnosed with HIV infection less than 5 years ago compared with more than 10 years. Cytological abnormalities were found in 13.4% (31/231) of women, most with high‐grade squamous intraepithelial lesions (16/51.6%). However, of women who had no cytological lesions or malignancy (200/86.6%), almost half were HPV DNA‐positive (99/49.5%). In conclusion, the prevalence of HPV among women living with HIV in Sergipe was high. There was a high frequency of high‐risk HPV infection, and a wide diversity of genotypes were detected, with HPV 16 being the most frequent.

show abstract

“…The unbalanced investments made by authorities in health, as well as the deficiencies in UCN prevention and control policies, became the main factors triggering the unsatisfactory results [43] . The studies highlighted the difficulty to provide treatment to women with alterations in the screening exams and low-quality diagnostics.…”

Section: Discussionmentioning

confidence: 99%

“…These findings evidence the need of reinforcing the continuous education of cytotechnologists, as well as of health professionals responsible for screening the target population. Good laboratory infrastructure and quality control standardization are also necessary [43] .…”

Section: Discussionmentioning

confidence: 99%

Policies and Programs for Cervical Cancer Prevention and Control in Public Health Services

Sperling¹,

Coser

2018

Int J Innov Educ Res

View full text Add to dashboard Cite

Aim: analyzing and assessing the scientific evidences about Health Services Administration through the practice of cervical cancer prevention programs and policies. Methodology: integrative literature review carried out in September/October 2017. Electronic search for publications in databases such as PubMed, Portal Periódicos CAPES, BVS, EBSCO and SciELO. Results and Discussion: eighteen articles approaching the topic were selected and their analyses resulted in the following thematic axes: Organization of cervical cancer prevention and control policies/programs, Follow-up and monitoring of actions taken and Quality Management of Cytopathological exams for diagnostic and treatment. There were differences between programs in the country, either in their recommendations or in their effectiveness. Final considerations: investments must be done in order to qualify technical procedures and involved health professionals, as well as to support health education in the target population. Policies and Programs for

show abstract

Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013

Cited by 25 publications

References 20 publications

Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil

Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil

Prevalence and genotype distribution of human papillomavirus in women living with HIV/AIDS in an area of Northeast Brazil

Policies and Programs for Cervical Cancer Prevention and Control in Public Health Services

Contact Info

Product

Resources

About